INTELLIPHARMACEUTICS INTERNATIONAL INC. Deferred Offering Costs
INTELLIPHARMACEUTICS INTERNATIONAL INC. had Deferred Offering Costs of CAD 0 as of 2018-11-30, per its 20-F filed 2019-03-04.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2019-03-04
- 2018-11-30: Deferred Offering Costs 0.00 CAD.
- 2017-11-30: Deferred Offering Costs 565.30K CAD.
- 2017-05-31: Deferred Offering Costs 562.77K CAD.
- 2017-02-28: Deferred Offering Costs 394.74K CAD.
CAD
| Period end | Deferred Offering Costs |
|---|---|
| 2018-11-30 | 0.00 CAD 20-F · filed 2019-03-04 |
| 2017-11-30 | 565.30K CAD 20-F · filed 2019-03-04 |
| 2017-05-31 | 562.77K CAD 6-K · filed 2017-07-11 |
| 2017-02-28 | 394.74K CAD 6-K · filed 2017-04-12 |
| 2016-11-30 | 386.38K CAD 20-F · filed 2018-03-01 |
| 2015-11-30 | 543.75K CAD 20-F · filed 2017-02-28 |
USD
| Period end | Deferred Offering Costs |
|---|---|
| 2018-08-31 | $814.88K 6-K · filed 2018-10-15 |
| 2018-05-31 | $431.91K 6-K · filed 2018-07-24 |
| 2017-11-30 | $565.30K 6-K · filed 2018-10-15 |
| 2015-11-30 | $543.75K 20-F · filed 2016-03-21 |
| 2014-11-30 | $271.38K 20-F · filed 2016-03-21 |
| 2014-05-31 | $271.38K 20-F · filed 2016-03-21 |
| 2013-11-30 | $419.78K 20-F · filed 2015-02-27 |
| 2011-01-31 | $2.36M 20-F · filed 2014-02-18 |
| 2010-11-30 | $224.67K 20-F · filed 2012-05-11 |